Krisztián Miklós KÁLLAY M.D., Ph.D. retweeted
ChatGPT's latest version, GPT-4, is now available and Microsoft is planning to put it *inside* MS Word.
But most academics still don't know how to use these apps smartly.
Here are five ways you can use ChatGPT intelligently for teaching and academic purposes (prompts included):
Krisztián Miklós KÁLLAY M.D., Ph.D. retweeted
Lili Kotmayer from our lab presenting her data on the GATA2 database generated in the framework of the GATA2HuMo consortium in Athens at the EWOG-MDS meeting. It will be online soon. Well done, Lili! @LKotmayer, @drkallay
Swimathon is a four-week community fundraising campaign. Our Démétér House is built for transplanted children and it is operating at full capacity all the time due to dramatically improved outcomes of the transplantation of leukemic children. 2021.swimathon.hu/swimmer/kr…
1
Bölcsisek, ezt is értetek teszem! 😍 pedig hogy utálok futni...! 😱 de kellenek a kilométerek a Démétér Alapítvány Tündérkertjéhez:
2021.swimathon.hu/swimmer/ka… @Orczy kert instagram.com/p/CPV-bxkHx7k/… – at Budapest, Hungary
Most tett közzé egy fényképet: @Zsámbék, Pest, Hungary instagram.com/p/CPTaUNXnjOC/… – at Zsámbék, Hungary
Krisztián Miklós KÁLLAY M.D., Ph.D. retweeted
A ship is safe in harbor, but that’s not what ships are for.
Ignaz Semmelweis is the doctor credited with championing handwashing - CNN cnn.com/2020/03/20/health/ig…
Very true indeed!
Very interesting. I observe this with many of my young colleagues @SFH @SFGM_TC @TheEBMT @JACIE_EBMT
Krisztián Miklós KÁLLAY M.D., Ph.D. retweeted
Moderating a round table discussion with Marcin Wlodarski at #genomicsLIVE in Basel/Switzerland. Integrating genomics into clinical trials.
Krisztián Miklós KÁLLAY M.D., Ph.D. retweeted
Preemptive Mitigation of CD19 CAR T Cell Cytokine Release Syndrome Without Attenuation of Anti-Leukemic Efficacy | Blood | American Society of Hematology ashpublications.org/blood/ar…
12y old boy with very severe aplastic anemia (vSAA) needs urgent hematopoietic stem cell transplantation because of S. aureus sepsis and uncontrollable thrombocytopenia. What donor option would you choose:
50%Severe hemophilic brother
50%Haplo parent
2 votes • Final results Krisztián Miklós KÁLLAY M.D., Ph.D. retweeted
My colleague Dr. Max S. Topp from @Uni_WUE will present at @ASCO Data from the BCMA-targeted #BiTE AMG 420 study, which was nomiated by @BrianDurieMD and @IMFmyeloma as Top 10 #asco2019 #myeloma abstracts released. #mmsm #cart myeloma.org/hope-blog/asco-2…
Krisztián Miklós KÁLLAY M.D., Ph.D. retweeted
When a resident/hospitalist gets called re a new acute leukemia patient in the ER, what are the management decisions to consider in the first few hr? Hopefully the image below lays out some of the things to keep in mind. Once again #medtwitter feel free to add/comment! #leusm
Thank you all!
The Open Acces 7th edition of the EBMT Handbook is available: link.springer.com/book/10.10…
Thank you Enric Carreras, Carlo Dufour, @Mohty_EBMT, Nicolaus Kröger and all the authors for this very useful and unparalleled description of current practices in #HSCT and #CellularTherapies
Krisztián Miklós KÁLLAY M.D., Ph.D. retweeted
CAR-T cell, CAR T-cell or CART cell ? @CChabannon @GruppSteve @Mohty_EBMT @DrMiguelPerales @BldCancerDoc @shahrukhhashmi @maljurf100 @drkomanduri @drjgauthier ?
50%CAR-T cell
45%CAR T-cell
5%CART cell
40 votes • Final results Krisztián Miklós KÁLLAY M.D., Ph.D. retweeted
Moji Hassan defends her PhD thesis at Emory and shows why GCSF mobilized grafts cause more GVHD: its the donor pDC!
PICC lines are associated with a significant higher incidence of thrombosis, CLABSI and malfunction compared to tunneled lines. #ASH18






















